Health Biotchnology Portfolio Fund Manager Performance Evaluation
| SHPAX Fund | USD 20.36 0.17 0.84% |
The fund retains a Market Volatility (i.e., Beta) of 0.17, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Health Biotchnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Health Biotchnology is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
...more| Expense Ratio Date | 28th of December 2022 | |
| Expense Ratio | 2.7500 |
Health |
Health Biotchnology Relative Risk vs. Return Landscape
If you would invest 2,141 in Health Biotchnology Portfolio on August 25, 2024 and sell it today you would lose (105.00) from holding Health Biotchnology Portfolio or give up 4.9% of portfolio value over 90 days. Health Biotchnology Portfolio is currently producing negative expected returns and takes up 0.7936% volatility of returns over 90 trading days. Put another way, 7% of traded mutual funds are less volatile than Health, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Health Biotchnology Current Valuation
Fairly Valued
Today
Please note that Health Biotchnology's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Health Biotchnology retains a regular Real Value of $20.49 per share. The prevalent price of the fund is $20.36. We determine the value of Health Biotchnology from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Health Biotchnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Health Mutual Fund. However, Health Biotchnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.36 | Real 20.49 | Hype 20.36 | Naive 19.7 |
The intrinsic value of Health Biotchnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Health Biotchnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Health Biotchnology Portfolio helps investors to forecast how Health mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health Biotchnology more accurately as focusing exclusively on Health Biotchnology's fundamentals will not take into account other important factors: Health Biotchnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Biotchnology's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Health Biotchnology Portfolio, and traders can use it to determine the average amount a Health Biotchnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0951
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SHPAX |
Estimated Market Risk
| 0.79 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Health Biotchnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Health Biotchnology by adding Health Biotchnology to a well-diversified portfolio.
Health Biotchnology Fundamentals Growth
Health Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Health Biotchnology, and Health Biotchnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Mutual Fund performance.
| Price To Earning | 18.07 X | ||||
| Price To Book | 2.64 X | ||||
| Price To Sales | 0.75 X | ||||
| Total Asset | 4.78 M | ||||
About Health Biotchnology Performance
Evaluating Health Biotchnology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Health Biotchnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Health Biotchnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.Things to note about Health Biotchnology performance evaluation
Checking the ongoing alerts about Health Biotchnology for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Health Biotchnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health Biotchnology generated a negative expected return over the last 90 days | |
| The fund maintains 95.99% of its assets in stocks |
- Analyzing Health Biotchnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health Biotchnology's stock is overvalued or undervalued compared to its peers.
- Examining Health Biotchnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health Biotchnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health Biotchnology's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Health Biotchnology's mutual fund. These opinions can provide insight into Health Biotchnology's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |